Regulation of mitotic function of Chk1 through phosphorylation at novel sites by cyclin-dependent kinase 1 (Cdk1)

Takashi Shiromizu1, Hidemasa Goto, Yasuko Tomono

  • 1Division of Biochemistry, Aichi Cancer Center Research Institute, Nagoya, Aichi 464-8681, Japan.

Insights

Checkpoint kinase 1 (Chk1) is phosphorylated during mitosis, with reduced phosphorylation at the metaphase-anaphase transition. Cyclin-dependent kinase 1 (Cdk1) regulates novel Chk1 phosphorylation sites, impacting mitotic progression.

Area of Science:

  • Cell biology
  • Molecular oncology
  • DNA damage response

Background:

  • Checkpoint kinase 1 (Chk1) is activated by ATR in response to DNA damage and replication stress, preventing premature mitosis.
  • The precise role and regulation of Chk1 during mitosis itself remain poorly understood.

Purpose of the Study:

  • To investigate the phosphorylation status and regulation of Chk1 during mitosis.
  • To identify novel Chk1 phosphorylation sites and their regulatory kinases in mitosis.

Main Methods:

  • Two-dimensional phosphopeptide mapping to identify Chk1 phosphorylation sites.
  • Treatment with specific kinase inhibitors (butyrolactone I, SB203580) and siRNA.
  • Cell cycle arrest using nocodazole followed by genotoxic stress (IR, UV).

Main Results:

  • Chk1 undergoes phosphorylation during mitosis, with a notable reduction at the metaphase-anaphase transition.
  • Novel phosphorylation sites, Ser286 and Ser301, were identified on Chk1.
  • Cyclin-dependent protein kinase 1 (Cdk1) inhibition reduced Chk1 phosphorylation at Ser301, suggesting Cdk1 as a key regulator.
  • Genotoxic stresses (IR, UV) did not induce canonical Chk1 phosphorylation at Ser317/Ser345 in mitotic cells.

Conclusions:

  • Mitotic Chk1 phosphorylation is regulated by novel sites, distinct from those activated by ATR during interphase.
  • Cyclin-dependent kinase 1 (Cdk1) plays a significant role in phosphorylating Chk1 during mitosis.
  • These findings suggest a Cdk1-mediated regulation of mitotic Chk1 function through novel phosphorylation sites.

Related Concept Videos

M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...